Market Recap: Sutro Biopharma Inc (STRO)’s Negative Momentum, Closing at 3.93

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

The closing price of Sutro Biopharma Inc (NASDAQ: STRO) was $3.93 for the day, down -9.45% from the previous closing price of $4.34. In other words, the price has decreased by -$9.45 from its previous closing price. On the day, 0.58 million shares were traded. STRO stock price reached its highest trading level at $4.46 during the session, while it also had its lowest trading level at $3.9.

Ratios:

Our analysis of STRO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.46 and its Current Ratio is at 4.46. In the meantime, Its Debt-to-Equity ratio is 1.88 whereas as Long-Term Debt/Eq ratio is at 1.81.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on May 08, 2024, initiated with a Buy rating and assigned the stock a target price of $12.

On November 09, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $12.

On October 06, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $10.Oppenheimer initiated its Outperform rating on October 06, 2023, with a $10 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 29 ’24 when Vasquez Nicki sold 12,185 shares for $5.00 per share. The transaction valued at 60,925 led to the insider holds 12,803 shares of the business.

Shtylla Brunilda sold 15,428 shares of STRO for $72,595 on Aug 28 ’23. The Chief Business Officer now owns 0 shares after completing the transaction at $4.71 per share. On Aug 25 ’23, another insider, Shtylla Brunilda, who serves as the Chief Business Officer of the company, sold 11,613 shares for $4.59 each. As a result, the insider received 53,282 and left with 12,928 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STRO now has a Market Capitalization of 321335296 and an Enterprise Value of -43618872. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.09 while its Price-to-Book (P/B) ratio in mrq is 2.50. Its current Enterprise Value per Revenue stands at -0.283 whereas that against EBITDA is 0.451.

Stock Price History:

The Beta on a monthly basis for STRO is 1.24, which has changed by -0.25708884 over the last 52 weeks, in comparison to a change of 0.2644323 over the same period for the S&P500. Over the past 52 weeks, STRO has reached a high of $6.13, while it has fallen to a 52-week low of $2.01. The 50-Day Moving Average of the stock is -5.71%, while the 200-Day Moving Average is calculated to be -0.17%.

Shares Statistics:

STRO traded an average of 991.03K shares per day over the past three months and 621120 shares per day over the past ten days. A total of 81.76M shares are outstanding, with a floating share count of 78.42M. Insiders hold about 4.09% of the company’s shares, while institutions hold 66.95% stake in the company. Shares short for STRO as of 1714435200 were 1945796 with a Short Ratio of 1.96, compared to 1711584000 on 2411685. Therefore, it implies a Short% of Shares Outstanding of 1945796 and a Short% of Float of 2.4.

Most Popular

[the_ad id="945"]